Abstract
Introduction
The COVID-19 pandemic has resulted in a historic public health crisis with widespread social and economic ramifications. The pandemic has also affected the blood supply, resulting in unprecedented and sustained blood shortages.Areas covered
This review describes the challenges of maintaining a safe and sufficient blood supply in the wake of natural disasters, humanitarian emergencies, and pandemics. The challenges, which are accentuated in low- and high-income countries, span the impact on human capacity (affecting blood donors and blood collections personnel alike), disruption to supply chains, and economic sustainability. COVID-19 imparted lessons on how to offset these challenges, which may be applied to future pandemics and public health crises.Expert opinion
Pandemic emergency preparedness plans should be implemented or revised by blood centers and hospitals to lessen the impact to the blood supply. Comprehensive planning should address the timely assessment of risk to the blood supply, rapid donor recruitment, and communication of need, measures to preserve safety for donors and operational staff, careful blood management, and resource sharing.References
Articles referenced by this article (97)
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
Clin Infect Dis, (3):e477-e486 2023
MED: 35579509
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
Proc Natl Acad Sci U S A, (17):9490-9496 2020
MED: 32253318
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
N Engl J Med, (7):610-618 2021
MED: 33406353
Meeting the Challenges of International Crises: The Experience of the Iranian Blood Transfusion Organization.
Disaster Med Public Health Prep, (3):410-413 2018
MED: 30064530
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.
Mayo Clin Proc, (9):1888-1897 2020
MED: 32861333
COVID-19 impact on Nigeria's national blood service commission - Lessons for Low- and Middle-Income Countries (LMICs).
Niger Postgrad Med J, (1):6-12 2022
MED: 35102944
Balancing Supply and Demand for Blood during the COVID-19 Pandemic.
Anesthesiology, (1):16-18 2020
MED: 32550680
Dwindling blood reserves: An ominous downside of COVID-19 pandemic.
Transfus Apher Sci, (5):102818 2020
MED: 32487511
Deployment of convalescent plasma for the prevention and treatment of COVID-19.
J Clin Invest, (6):2757-2765 2020
MED: 32254064
Show 10 more references (10 of 97)
Citations & impact
This article has not been cited yet.
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/154607449
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1080/17474086.2023.2209716
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID-19 pandemic.
Vox Sang, 117(6):822-830, 08 Mar 2022
Cited by: 15 articles | PMID: 35262978 | PMCID: PMC9115426
Business and continuity of operations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.
Chest, 146(4 suppl):e103S-17S, 01 Oct 2014
Cited by: 10 articles | PMID: 25144857 | PMCID: PMC4504250
Review Free full text in Europe PMC
Legal preparedness: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.
Chest, 146(4 suppl):e134S-44S, 01 Oct 2014
Cited by: 9 articles | PMID: 25144203 | PMCID: PMC4677050
Review Free full text in Europe PMC
Availability and safety of blood transfusion during humanitarian emergencies.
East Mediterr Health J, 24(8):778-788, 10 Oct 2018
Cited by: 5 articles | PMID: 30328608
Review
Funding
Funders who supported this work.
NHLBI NIH HHS (1)
Grant ID: K23 HL151826
the National Heart Lung and Blood Institute (1)
Grant ID: 1K23HL151826